Citation
Select
Touboul P, Brugada J, Capucci A, Crijns HJ, Edvardsson N, Hohnloser SH; The DAFNE investigators
Dronedarone for prevention of atrial fibrillation: a dose-ranging study
Eur Heart J. 2003 Aug;24(16):1481-7
Citation
Select
Gronefeld GC, Lilienthal J, Kuck KH, Hohnloser SH, Pharmacological Intervention in Atrial Fibrillation (PIAF) Study investigators
Impact of rate versus rhythm control on quality of life in patients with persistent atrial fibrillation. Results from a prospective randomized study
Eur Heart J. 2003 Aug;24(15):1430-6
Citation
Select
De Simone A, De Pasquale M, De Matteis C, Canciello M, Manzo M, Sabino L, Alfano F, Di Mauro M, Campana A, De Fabrizio G, Vitale DF, Turco P, Stabile G.
VErapamil plus antiarrhythmic drugs reduce atrial fibrillation recurrences after an electrical cardioversion (VEPARAF Study)
Eur Heart J. 2003 Aug;24(15):1425-9
Citation
Select
Wattigney WA, Mensah GA, Croft JB
Increasing trends in hospitalization for atrial fibrillation in the United States, 1985 through 1999: implications for primary prevention
Circulation. 2003 Aug 12;108(6):711-6
Citation
Select
Singh SN, Singh BN, Reda DJ, Fye CL, Ezekowitz MD, Fletcher RD, Sharma SC, Atwood JE, Jacobson AK, Lewis HD Jr, Antman EM, Falk RH, Lopez B, Tang XC.
Comparison of sotalol versus amiodarone in maintaining stability of sinus rhythm in patients with atrial fibrillation (Sotalol-Amiodarone Fibrillation Efficacy Trial [Safe-T])
Am J Cardiol. 2003 Aug 15;92(4):468-72